← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

A

$ Value

$0

Shares

62,000

Price

$0

Filed

Feb 25

Insider

Name

Struthers Richard Scott

Title

President & CEO

CIK

0001746298

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-23

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

426,759

Footnotes

The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 1, 2027. | The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 23, 2026.

Filing Info

Accession No.

0001628280-26-011730

Form Type

4

Issuer CIK

0001658247

Struthers Richard Scott's History

Date Ticker Type Value
2026-02-23 CRNX A $0
2026-02-23 CRNX A $0
2025-12-18 CRNX M $152K
2025-12-18 CRNX M $434K
2025-12-18 CRNX M $0
2025-12-18 CRNX M $0
2025-09-26 CRNX $180K
2025-05-14 CRNX G $0
2025-05-14 CRNX G $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Vivaldi Coelho Rogerio $181K 2026-03-12
Schilke Tobin
Chief Financial Officer
$266K 2026-03-03
Okey Stephanie $119K 2026-03-03
Struthers Richard Scott
President & CEO
2026-02-23
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08
Knight Jeff E.
Chief Operating Officer
2026-02-23
Betz Stephen F.
Chief Scientific Officer
2026-02-23
Kalofonos Isabel
Chief Commercial Officer
2026-02-23